The Effectiveness of Oral Acyclovir in the Treatment of Molluscum Contagiosum in Children
NCT ID: NCT04476186
Last Updated: 2020-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
35 participants
INTERVENTIONAL
2020-06-15
2021-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Phase 3 Molluscum Contagiosum Efficacy and Safety Study
NCT04535531
A Study of VBP-245 in Pediatric Patients With Molluscum Contagiosum
NCT03077750
Comparative Efficacy of 10% Potassium Hydroxide Solution Versus Cryotherapy in Molluscum Contagiosum
NCT05897112
Intralesional Injection of Acyclovir Versus Candida Antigen in Treatment of Plantar Warts
NCT05429151
Safety and Efficacy of Topical NVC-422 Gel in Impetigo
NCT01367314
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Site of the study: The outpatient dermatological clinic in Assiut university hospital.
Participants: children (2 -16) years' old attending dermatological clinic in Assiut university hospital and their parents.
Methodology in details:
1. We will use the social media as " Facebook" to invite patient to visit the clinic and follow up them due to the protective measures of covid 19.
2. Diagnosis of the patient with molluscum contagiosum according to the clinical picture
3. Collecting data including personal and clinical data through interviewing the patient and his or her parents
4. Pictures of the lesions will be taken before and after treatment after patient consent.
5. We will Randomly assigning the patient to either treatment group or controlled group according to simple random table
6. Prescribing the treatment according to the patient group
7. Follow up of the patient after 1 weak and each week according to the response to treatment or presence of complication
Inclusion criteria:
Children (5 -15) years old with Molluscum contagiosum.
Exclusion criteria:
1. Molluscum contagiosum with Inflamed spot
2. Known immune compromised children
3. Molluscum lesion in the eye lid.
4. Children with renal impairment.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
treatment group
200 mg of oral acyclovir 5 timed per day for 5 days per week for maximum 1 month
Acyclovir
oral syrp
controlled group
KOH 10 % solution local application with apiece of cotton 2 time per day maximum for 1 month
KOH 10 %
solution for local application
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Acyclovir
oral syrp
KOH 10 %
solution for local application
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2 Years
16 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
assistant professor Ghada M. Khafagy
UNKNOWN
Dr. Marwa Diaaeldeen Abbass Hasan
UNKNOWN
Prof. Dr. Emad Taha Abd-Elahim Ebiad
UNKNOWN
Dalia Mahran
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Dalia Mahran
professor of public health and community medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ghada Mahmoud, Assist Prof
Role: PRINCIPAL_INVESTIGATOR
Cairo University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Hamdy Gomaa
Asyut, New Assiut City, Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
site of study assiut U H
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.